Delaware Bankruptcy Court

Case number: 1:26-bk-11360 - BioXcel Therapeutics, Inc. - Delaware Bankruptcy Court

Case Information
Case title
BioXcel Therapeutics, Inc.
Chapter
11
Judge
Filed
08/27/2026
Last Filing
08/28/2026
Asset
Yes
Vol
v
Docket Header

VerifDue, PlnDue, DsclsDue, SealedDoc(s)




U.S. Bankruptcy Court
District of Delaware (Delaware)
Bankruptcy Petition #: 26-11360

Assigned to:
Chapter 11
Voluntary
Asset

Date filed:  08/27/2026

Debtor

BioXcel Therapeutics, Inc.

555 Long Wharf Drive
12th Floor
New Haven, CT 06511
NEW HAVEN-CT
Tax ID / EIN: XX-XXXXXXX

represented by
Sean Matthew Beach

Young, Conaway, Stargatt & Taylor
1000 North King Street
Wilmington, DE 19801
302-571-6600
Fax : 302-576-3281
Email: [email protected]

Jared W Kochenash

Young Conaway
Rodney Square
1000 N. King Street
Wilmington, DE 19801
302-571-6700
Email: [email protected]

U.S. Trustee

U.S. Trustee

Office of the United States Trustee
J. Caleb Boggs Federal Building
844 King Street, Suite 2207
Lockbox 35
Wilmington, DE 19801
(302)-573-6491
 
 

Latest Dockets
Date Filed#Docket Text
08/28/202616Docket Text
(REDACTED) List of Creditors (related document(s)15) Filed by BioXcel Therapeutics, Inc.. (Kochenash, Jared) (Entered: 08/28/2026)
08/28/202615Docket Text
[SEALED] List of Creditors Filed by BioXcel Therapeutics, Inc.. (Kochenash, Jared) (Entered: 08/28/2026)
08/28/202614Docket Text
Declaration of Daun Chung in Support of the Debtors' Motion for an Order (I) Approving Bidding Procedures for the Sale of the Debtors' Assets, (II) Approving the Debtors' Entry into the Stalking Horse APA and Granting Bid Protections, (III) Approving Assumption and Assignment Procedures, (IV) Scheduling an Auction and Sale Hearing and Approving Forms and Manner of Notice Thereof, and (V) Granting Certain Related Relief (related document(s)13) Filed by BioXcel Therapeutics, Inc.. (Kochenash, Jared) (Entered: 08/28/2026)
08/28/202613Docket Text
Motion For Sale of Property Free and Clear of Liens(FEE) - Motion of the Debtors for an Order (I) Approving Bidding Procedures for the Sale of the Debtors' Assets, (II) Approving the Debtors' Entry into the Stalking Horse APA and Granting Bid Protections, (III) Approving Assumption and Assignment Procedures, (IV) Scheduling an Auction and Sale Hearing and Approving Forms and Manner of Notice Thereof, and (V) Granting Certain Related Relief Fee Amount $199 Filed by BioXcel Therapeutics, Inc.. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C) (Kochenash, Jared) (Entered: 08/28/2026)
08/27/202612Docket Text
Motion Regarding Chapter 11 First Day Motions - 12.Motion of the Debtors for Entry of Interim and Final Orders (I) Establishing Notice and Objection Procedures for Transfers of and Declarations of Worthlessness With Respect to the Equity Securities; (II) Establishing a Record Date for Notice and Sell-Down Procedures for Trading in Claims Against the Debtors Estates; and (III) Granting Related Relief Filed By BioXcel Therapeutics, Inc. (Kochenash, Jared) (Entered: 08/27/2026)
08/27/202611Docket Text
Motion to Maintain Bank Accounts - Motion for Interim and Final Orders (I) Authorizing the Debtors to (A) Continue to Maintain their Cash Management System, and (B) Honor Certain Prepetition Obligations Related Thereto; (II) Waiving Certain Operating Guidelines; (III) Suspending Time to Comply with Section 345(b) of the Bankruptcy Code; and (IV) Granting Related Relief Filed By BioXcel Therapeutics, Inc. (Kochenash, Jared) (Entered: 08/27/2026)
08/27/202610Docket Text
Motion to Pay Sales and Use Taxes - Motion for Interim and Final Orders (I) Authorizing the Debtors to Pay Certain Prepetition Taxes and Fees and Related Obligations; (II) Authorizing the Banks to Honor and Process Check and Electronic Transfer Requests Related Thereto; and (III) Granting Related Relief Filed By BioXcel Therapeutics, Inc. (Kochenash, Jared) (Entered: 08/27/2026)
08/27/20269Docket Text
Motion Regarding Chapter 11 First Day Motions - Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Redact Certain Personally Identifiable Information of Individuals; (II) Modifying the Requirement to File a List of All Equity Security Holders and Modifying Notice Thereto; and (III) Granting Related Relief Filed By BioXcel Therapeutics, Inc. (Kochenash, Jared) (Entered: 08/27/2026)
08/27/20268Docket Text
Motion to Continue Customer Programs - Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Maintain and Administer their Existing Customer Programs and Honor Certain Prepetition Obligations Related Thereto; (II) Authorizing the Banks to Honor and Process Check and Electronic Transfer Requests Related Thereto; and (III) Granting Related Relief Filed By BioXcel Therapeutics, Inc. (Kochenash, Jared) (Entered: 08/27/2026)
08/27/20267Docket Text
Motion to Pay Employee Wages - Motion for Entry of Interim and Final Orders (I) Authorizing Debtors to (A) Pay Certain Prepetition Employment Obligations and Compensation Obligations and (B) Maintain Employee Benefits Programs and Compensation Obligations; and (II) Granting Related Relief Filed By BioXcel Therapeutics, Inc. (Kochenash, Jared) (Entered: 08/27/2026)